Enhancing Joint Replacement Outcomes Through National Data Linkage
Funder
National Health and Medical Research Council
Funding Amount
$776,063.00
Summary
This is an Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) project that involves linking Registry data with state and federal government health datasets. This will help to better understand the complications and factors affecting the rate of complication after hip, knee and shoulder joint replacement. This information will be used to improve outcomes for patients having this surgery.
Deaths In Young People Involved In The Youth Justice System: Towards Evidence-based Prevention
Funder
National Health and Medical Research Council
Funding Amount
$620,705.00
Summary
Young offenders have complex health needs and are at dramatically increased risk of preventable death due to drug overdose, suicide and injury. In order to inform effective prevention, a more detailed understanding of mortality in these young people is required. This project will examine all deaths in young offenders in Queensland from 1993 to 2015, identify targets for prevention, and recommend policy reforms and interventions that are supported by evidence and are culturally appropriate.
Evidence-based Recommendations For Interpregnancy Intervals In High-income Countries
Funder
National Health and Medical Research Council
Funding Amount
$423,305.00
Summary
This study will identify the optimal and harmful interpregnancy intervals for a range of maternal and child outcomes in three high-income countries. With a study population of more than 7.5 million births and a longitudinal study design that matches pregnancies to the same women, this study will inform new interpregnancy interval recommendations for high-income countries that will lead to a reduction in avoidable excess morbidities attributable to uninformed pregnancy planning.
Harnessing Multiple Large Datasets To Answer Critical Questions On Diabetes Epidemiology
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
This proposal will examine novel causes and consequences of diabetes using three approaches. Firstly, it will examine diabetes trends. Secondly, it will use the Australian Diabetes Registry linked to several key government database to explore important research questions, related to diabetes treatment, dementia and endstage kidney disease, which previously were not able to be answered. Thirdly, it will examine the role of environmental pollutants in the development of chronic disease.
Developing A Framework To Evaluate Low Value Prescribing In The Australian Health Care Setting
Funder
National Health and Medical Research Council
Funding Amount
$124,608.00
Summary
The aim of this project is to develop a framework to evaluate the quality of prescribing in Australia using routinely collected administrative health data. Given growing concerns regarding the quality of prescribing of psychotropic medicines and opioids, these medicines will be e focus of the study. Patterns, quality markers and health and financial consequences of poor prescribing will be assessed.
Combating Escalating Harms Associated With Pharmaceutical Opioid Use
Funder
National Health and Medical Research Council
Funding Amount
$925,767.00
Summary
Increases in opioid use have been accompanied by increased opioid harms. But there is a lack of population-level evidence about drivers of long-term prescribed opioid use, dependence, overdose and other harms. Using linked data, we will fill these gaps using a cohort of all people in NSW prescribed opioids since 2002, linked to datasets containing information on health, social and health service utilisation, that will permit a comprehensive assessment of the risks of all prescribed opioids.
Big Data To Real World Evidence: Informing Pharmaceutical Policy Decisions Around Targeted Cancer Medicines
Funder
National Health and Medical Research Council
Funding Amount
$86,073.00
Summary
The proposed research will examine the use of targeted cancer therapies in Australia. At present there is little evidence around how these medications are being used in the real world, medical services their use requires, and costs associated with their use. Analysing linked, routinely collected health data, this project will generate new scientific and methodological knowledge about the use and impact of targeted cancer therapies available via publicly funded access programs in Australia.